AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
Israel's BIGITech tech index rose 25% in 2019 as Israeli technology firms hit record highs. A new platform, The Jerusalem Portfolio, now allows global investors to hold fractional stakes in over 100
Follow